A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD-Reference-Cited by-同舟云学术

A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD

Published:2017-03-13 Issue:8 Volume:37 Page:1209-1218
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Younossi Zobair M.¹²³^ORCID,Stepanova Maria³,Henry Linda³,Racila Andrei¹³,Lam Brian¹,Pham Huong T.¹,Hunt Sharon³

Affiliation:

1. Center For Liver Disease; Department of Medicine; Inova Fairfax Hospital; Falls Church VA USA

2. Betty and Guy Beatty Center for Integrated Research; Inova Health System; Falls Church VA USA

3. Center for Outcomes Research in Liver Diseases; Washington DC USA

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13391/fullpdf

Reference43 articles.

1. Validation of health-related quality of life instruments;Cohen;Hepatology,1999

2. Health-related quality of life. A guide for the health professional;Nanda;Eval Health Prof,1998

3. Committee for Economic Development Adjusting the Prescription-Recommendations for Health Care Reform 2015. March http://ced.org/reports

4. Claxton G Cox C Gonzales S Kamal R Levitt L Kaiser Family Foundation Measuring the quality of healthcare in the U.S http://www.healthsystemtracker.org/insight/measuring-the-quality-of-healthcare-in-the-u-s/

5. Incentivising improvements in health care delivery Health Economics;Oliver;Policy Law,2015

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease;Digestive Diseases and Sciences;2023-12-07

2. Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK Study;Clinical Gastroenterology and Hepatology;2023-11

3. Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia;Sports Medicine;2023-09-11

4. Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort;BMJ Open;2023-08

5. Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease;PLOS ONE;2023-07-14